loading
Pacific Biosciences Of California Inc stock is traded at $1.5858, with a volume of 10.56M. It is down -0.31% in the last 24 hours and down -19.70% over the past month. Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.
See More
Previous Close:
$1.595
Open:
$1.69
24h Volume:
10.56M
Relative Volume:
1.17
Market Cap:
$438.18M
Revenue:
$188.87M
Net Income/Loss:
$-400.38M
P/E Ratio:
-1.2487
EPS:
-1.27
Net Cash Flow:
$-260.90M
1W Performance:
-35.37%
1M Performance:
-19.70%
6M Performance:
-21.29%
1Y Performance:
-81.07%
1-Day Range:
Value
$1.57
$1.69
1-Week Range:
Value
$1.56
$2.66
52-Week Range:
Value
$1.16
$10.65

Pacific Biosciences Of California Inc Stock (PACB) Company Profile

Name
Name
Pacific Biosciences Of California Inc
Name
Phone
650-521-8000
Name
Address
1305 O'BRIEN DRIVE, MENLO PARK, CA
Name
Employee
796
Name
Twitter
@pacbio
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
PACB's Discussions on Twitter

Compare PACB with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
PACB 1.585 438.18M 188.87M -400.38M -260.90M -1.27
ABT 117.50 202.64B 41.22B 5.77B 6.49B 2.94
SYK 392.19 148.70B 21.97B 3.59B 3.21B 6.74
BSX 90.70 133.82B 15.91B 1.79B 1.89B 0.82
MDT 87.89 112.92B 32.58B 3.93B 5.15B 2.71
EW 70.12 40.88B 6.60B 4.16B 490.10M 2.34

Pacific Biosciences Of California Inc Stock (PACB) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-14-23 Initiated Guggenheim Neutral
Dec-14-23 Initiated Stephens Overweight
Dec-13-23 Initiated Wolfe Research Peer Perform
Nov-17-23 Upgrade UBS Neutral → Buy
Oct-31-23 Upgrade Cantor Fitzgerald Neutral → Overweight
Sep-28-23 Initiated Bernstein Outperform
Jul-05-23 Resumed JP Morgan Overweight
Jun-30-23 Initiated Goldman Buy
May-10-23 Initiated Barclays Equal Weight
Mar-31-23 Upgrade TD Cowen Market Perform → Outperform
Feb-02-23 Initiated UBS Neutral
Jan-20-23 Downgrade Cantor Fitzgerald Overweight → Neutral
Jan-05-23 Initiated Scotiabank Sector Outperform
Jan-21-22 Resumed Cantor Fitzgerald Overweight
Jan-06-22 Resumed Piper Sandler Neutral
Oct-15-21 Resumed Cowen Market Perform
Sep-27-21 Initiated Canaccord Genuity Buy
Feb-11-21 Upgrade Piper Sandler Neutral → Overweight
Nov-03-20 Downgrade Piper Sandler Overweight → Neutral
Oct-02-20 Upgrade JP Morgan Neutral → Overweight
Sep-09-20 Initiated Morgan Stanley Equal-Weight
Jun-02-20 Resumed Cantor Fitzgerald Overweight
Mar-09-20 Resumed Cantor Fitzgerald Overweight
Oct-15-19 Upgrade Piper Jaffray Neutral → Overweight
Apr-02-19 Downgrade Stephens Overweight → Equal-Weight
Oct-19-18 Initiated Cowen Outperform
Nov-03-17 Downgrade First Analysis Sec Overweight → Equal-Weight
Sep-28-17 Downgrade CL King Buy → Neutral
Nov-03-16 Reiterated Cantor Fitzgerald Buy
Jun-27-16 Initiated CL King Buy
Apr-15-16 Initiated First Analysis Sec Overweight
Feb-04-16 Downgrade Piper Jaffray Overweight → Neutral
Jan-04-16 Reiterated Cantor Fitzgerald Buy
Oct-23-15 Upgrade Piper Jaffray Neutral → Overweight
Aug-27-15 Initiated Cantor Fitzgerald Buy
Feb-04-15 Reiterated Maxim Group Buy
Sep-26-13 Reiterated Maxim Group Buy
Jan-14-13 Reiterated Maxim Group Buy
View All

Pacific Biosciences Of California Inc Stock (PACB) Latest News

pulisher
04:41 AM

Sumitomo Mitsui Trust Group Inc. Cuts Stock Holdings in Pacific Biosciences of California, Inc. (NASDAQ:PACB) - MarketBeat

04:41 AM
pulisher
01:56 AM

FY2024 EPS Estimates for PACB Lowered by Cantor Fitzgerald - MarketBeat

01:56 AM
pulisher
Nov 14, 2024

DNA Sequencing Market to Grow by USD 17.34 Billion (2024-2028), Driven by Rising NGS Adoption, AI-Powered Report Explores Market EvolutionTechnavio - The Malaysian Reserve

Nov 14, 2024
pulisher
Nov 14, 2024

Pacific Biosciences of California (NASDAQ:PACB) Upgraded by UBS Group to "Hold" Rating - MarketBeat

Nov 14, 2024
pulisher
Nov 13, 2024

Pacific Biosciences CCO departs amid restructuring By Investing.com - Investing.com Australia

Nov 13, 2024
pulisher
Nov 13, 2024

Pacific Biosciences CCO departs amid restructuring - Investing.com India

Nov 13, 2024
pulisher
Nov 12, 2024

PACB Stock Falls Despite Q3 Earnings Beat, Revenues Decline Y/Y - MSN

Nov 12, 2024
pulisher
Nov 12, 2024

Pacific Biosciences' Cost Cuts Won't Offset Rising Competition (NASDAQ:PACB) - Seeking Alpha

Nov 12, 2024
pulisher
Nov 12, 2024

Pacific Biosciences of California Inc (PACB) Quarterly 10-Q Report - Quartzy

Nov 12, 2024
pulisher
Nov 12, 2024

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought - The Motley Fool

Nov 12, 2024
pulisher
Nov 12, 2024

Pacific Biosciences of California (NASDAQ:PACB) Trading Up 5.3% Following Analyst Upgrade - MarketBeat

Nov 12, 2024
pulisher
Nov 12, 2024

Pacific Biosciences of California Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

Nov 12, 2024
pulisher
Nov 12, 2024

UBS Downgrades Pacific Biosciences of California (PACB) - MSN

Nov 12, 2024
pulisher
Nov 11, 2024

Pacific Biosciences of California (PACB) Reports Q3 Loss, Misses Revenue Estimates - MSN

Nov 11, 2024
pulisher
Nov 11, 2024

Cathie Wood's ARK sells Unity, buys Pacific Biosciences stock By Investing.com - Investing.com Nigeria

Nov 11, 2024
pulisher
Nov 11, 2024

Cathie Wood's ARK sells Unity, buys Pacific Biosciences stock - Investing.com

Nov 11, 2024
pulisher
Nov 11, 2024

PacBio’s $459 Million Convertible Note Exchange Offering - Global Legal Chronicle

Nov 11, 2024
pulisher
Nov 11, 2024

Scotiabank Lowers Pacific Biosciences of California (NASDAQ:PACB) Price Target to $6.00 - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

Pacific Biosciences of California Target of Unusually High Options Trading (NASDAQ:PACB) - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

Pacific Biosciences of California (NASDAQ:PACB) Rating Lowered to "Neutral" at UBS Group - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

Pacific Biosciences of California (NASDAQ:PACB) Price Target Raised to $2.50 - MarketBeat

Nov 11, 2024
pulisher
Nov 09, 2024

Earnings Update: Pacific Biosciences of California, Inc. (NASDAQ:PACB) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts - Yahoo Finance

Nov 09, 2024
pulisher
Nov 09, 2024

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 09, 2024
pulisher
Nov 09, 2024

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Nov 09, 2024
pulisher
Nov 08, 2024

Wilson Sonsini Advises PacBio on $459 Million Convertible Note Exchange - Wilson Sonsini

Nov 08, 2024
pulisher
Nov 08, 2024

PacBio to Present at 4 Major Healthcare Investor Conferences Through Year-End | PACB Stock News - StockTitan

Nov 08, 2024
pulisher
Nov 08, 2024

Pacific Biosciences of California Inc (PACB) Q3 2024 Earnings Ca - GuruFocus.com

Nov 08, 2024
pulisher
Nov 08, 2024

Pacific Biosciences of California (NASDAQ:PACB) Shares Gap DownShould You Sell? - MarketBeat

Nov 08, 2024
pulisher
Nov 08, 2024

Pacific Biosciences of California Inc (PACB) Q3 2024 Earnings Call Highlights: Navigating ... By GuruFocus - Investing.com Canada

Nov 08, 2024
pulisher
Nov 08, 2024

Pacific Biosciences of California Inc (PACB) Q3 2024 Earnings Call Highlights: Navigating ... - Yahoo Finance

Nov 08, 2024
pulisher
Nov 08, 2024

Pacific Biosciences: Q3 Earnings Snapshot - CTPost

Nov 08, 2024
pulisher
Nov 08, 2024

Pacific Biosciences of California (FRA:P09) 5-Day RSI : 64.86 (As of Nov. 08, 2024) - GuruFocus.com

Nov 08, 2024
pulisher
Nov 08, 2024

PacBio stock falls 16% post-market after Q3 revenue miss - MSN

Nov 08, 2024
pulisher
Nov 07, 2024

Pacific Biosciences of California, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 07, 2024
pulisher
Nov 07, 2024

Pacific Biosciences of California Inc (PACB) Q3 2024 Earnings: E - GuruFocus.com

Nov 07, 2024
pulisher
Nov 07, 2024

PacBio Announces Third Quarter 2024 Financial Results - GlobeNewswire

Nov 07, 2024
pulisher
Nov 07, 2024

PacBio Announces a Private Convertible Exchange Transaction of $459 Million Principal Amount of 1.50% Convertible Senior Notes due 2028 - StockTitan

Nov 07, 2024
pulisher
Nov 07, 2024

Strong week for Pacific Biosciences of California (NASDAQ:PACB) shareholders doesn't alleviate pain of three-year loss - Simply Wall St

Nov 07, 2024
pulisher
Nov 07, 2024

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Stock Rockets 56% But Many Are Still Ignoring The Company - Simply Wall St

Nov 07, 2024
pulisher
Nov 06, 2024

PacBio Unveils the Vega System, a New Sequencing Platform Bringing HiFi to the Benchtop - StockTitan

Nov 06, 2024
pulisher
Nov 06, 2024

Pacific Biosciences of California Inc (PACB) Q3 2024 Earnings Re - GuruFocus.com

Nov 06, 2024
pulisher
Nov 05, 2024

Vanguard Group Inc's Strategic Reduction in Pacific Biosciences of California Inc - GuruFocus.com

Nov 05, 2024
pulisher
Nov 04, 2024

Reasons to Retain PacBio Stock in Your Portfolio for Now - MSN

Nov 04, 2024
pulisher
Nov 04, 2024

Curious about Pacific Biosciences (PACB) Q3 Performance? Explore Wall Street Estimates for Key Metrics - Yahoo Finance

Nov 04, 2024
pulisher
Nov 04, 2024

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Shares Sold by Assenagon Asset Management S.A. - MarketBeat

Nov 04, 2024
pulisher
Oct 31, 2024

Pacific Biosciences of California (PACB) Advances While Market Declines: Some Information for Investors - Yahoo Finance

Oct 31, 2024
pulisher
Oct 31, 2024

Pacific Biosciences of California (PACB) Scheduled to Post Earnings on Thursday - MarketBeat

Oct 31, 2024
pulisher
Oct 30, 2024

Pacific Biosciences (PACB): Promising Gene Editing Stock With Innovating Technology - Insider Monkey

Oct 30, 2024
pulisher
Oct 30, 2024

Volta Labs joins PacBio Compatible program to help PacBio customers scale sequencing through automated library prep - Quantisnow

Oct 30, 2024
pulisher
Oct 30, 2024

Volta Labs joins PacBio Compatible program to help PacBio customers scale sequencing through automated library prep – Company AnnouncementFT.com - Financial Times

Oct 30, 2024
pulisher
Oct 29, 2024

Pacific Biosciences of California (NASDAQ:PACB) Shares Up 5.7%Should You Buy? - MarketBeat

Oct 29, 2024

Pacific Biosciences Of California Inc Stock (PACB) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
medical_devices STE
$217.96
price down icon 0.99%
medical_devices ZBH
$113.33
price up icon 0.74%
medical_devices PHG
$25.98
price up icon 0.56%
$77.45
price up icon 2.05%
$82.35
price up icon 0.78%
medical_devices EW
$70.12
price up icon 3.64%
Cap:     |  Volume (24h):